'Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.' plus Do we have enough pieces to solve the pyrazinamide puzzle?

被引:14
作者
Anthony, R. M. [1 ]
den Hertog, A. L. [2 ]
van Soolingen, D. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands
[2] HU Univ Appl Sci Utrecht, Inst Life Sci & Chem, Utrecht, Netherlands
关键词
MYCOBACTERIUM-TUBERCULOSIS; RESISTANT TUBERCULOSIS; BACILLUS-SUBTILIS; PH;
D O I
10.1093/jac/dky060
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A low pH was assumed to be required for the activity of pyrazinoic acid (the active formof pyrazinamide) against Mycobacteriumtuberculosis, but recently activity has been demonstrated at neutral pH. Renewed interest in pyrazinamide has led to an increasing number of potential targets and the suspicion that pyrazinamide is a 'dirty drug'. However, it is our opinion that the recent demonstration that pyrazinoic acid is active against PanD provides an alternative explanation for the secret of pyrazinamide's unusual activity. In this article we propose that PanD is the primary target of pyrazinoic acid but expression of pyrazinoic acid susceptibility requires an intact stress response. As the mycobacterial stress response requires the interaction of a number of genes, disruption of any could result in an inability to enter the susceptible phenotype. We believe this model can explain most of the recent observations of the seemingly diverse spectrumof activity of pyrazinamide.
引用
收藏
页码:1750 / 1754
页数:5
相关论文
共 37 条
[1]  
Almeida Deepak V, 2014, Mycobact Dis, V4, P145
[2]   Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment [J].
Anthony, R. M. ;
Cynamon, M. ;
Hoffner, S. ;
Werngren, J. ;
den Hertog, A. L. ;
van Soolingen, D. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
[3]  
Anthony Richard M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS71, DOI 10.1016/j.ijmyco.2016.08.009
[4]   Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients [J].
Aung, K. J. M. ;
Van Deun, A. ;
Declercq, E. ;
Sarker, M. R. ;
Das, P. K. ;
Hossain, M. A. ;
Rieder, H. L. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (10) :1180-1187
[5]   New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State [J].
Cano-Muniz, Santiago ;
Anthony, Richard ;
Niemann, Stefan ;
Alffenaar, Jan-Willem C. .
CLINICAL MICROBIOLOGY REVIEWS, 2018, 31 (01)
[6]   Evolution and transmission of drug-resistant tuberculosis in a Russian population [J].
Casali, Nicola ;
Nikolayevskyy, Vladyslav ;
Balabanova, Yanina ;
Harris, Simon R. ;
Ignatyeva, Olga ;
Kontsevaya, Irina ;
Corander, Jukka ;
Bryant, Josephine ;
Parkhill, Julian ;
Nejentsev, Sergey ;
Horstmann, Rolf D. ;
Brown, Timothy ;
Drobniewski, Francis .
NATURE GENETICS, 2014, 46 (03) :279-+
[7]   RelE toxins from Bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA [J].
Christensen, SK ;
Gerdes, K .
MOLECULAR MICROBIOLOGY, 2003, 48 (05) :1389-1400
[8]   Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature [J].
den Hertog, Alice L. ;
Menting, Sandra ;
Pfeltz, Richard ;
Warns, Matthew ;
Siddiqi, Salman H. ;
Anthony, Richard M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) :4956-4960
[9]   Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite? [J].
den Hertog, Alice L. ;
Sengstake, Sarah ;
Anthony, Richard M. .
PATHOGENS AND DISEASE, 2015, 73 (06)
[10]   Proteomics Analysis of Three Different Strains of Mycobacterium tuberculosis under In vitro Hypoxia and Evaluation of Hypoxia Associated Antigen's Specific Memory T Cells in Healthy Household Contacts [J].
Devasundaram, Santhi ;
Gopalan, Akilandeswari ;
Das, Sulochana D. ;
Raja, Alamelu .
FRONTIERS IN MICROBIOLOGY, 2016, 7